S&P Futures
4,068.25 -7.25 (-0.18%) Dow Futures
34,427.00 -32.00 (-0.09%) Nasdaq Futures
11,985.25 -25.00 (-0.21%) Russell 2000 Futures
1,892.80 -1.60 (-0.08%) Crude Oil
81.43 +1.45 (+1.81%) Gold
1,819.80 +10.20 (+0.56%)
Cosmos Holdings Inc. (COSM)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.3978 |
| Open | 0.4665 |
| Bid | 0.5315 x 1000 |
| Ask | 0.5325 x 900 |
| Day's Range | 0.4226 - 0.6100 |
| 52 Week Range | 0.0680 - 4.4500 |
| Volume | |
| Avg. Volume | 46,319,855 |
| Market Cap | 95.677M |
| Beta (5Y Monthly) | 1.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.1110 |
| Earnings Date | May 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for COSM
Related Research
- Cosmos Holdings Inc.Daily – Vickers Top Buyers & Sellers for 11/23/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat12 days agoArgus Research
- ACCESSWIRE
Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company
Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, provided a summary regarding recent share activity, including the participation of CEO, Greg Siokas on all capital raises.
- ACCESSWIRE
Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management
Cosmos Health, Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered the development phase for CCX0722, an innovative product for obesity and weight management, based on the effectiveness of biocompatible 3D spatial fillers, from natural ingredients.
- ACCESSWIRE
Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda.
Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that its Sky Premium Life luxury food supplement brand will be sold on Ronda, the official inflight magazine of the airline company Iberia of BRITISH AIRWAYS group.
